# Maternal Health Market

> Maternal Health Market Research Report Information By Type of Pregnancy (Intrauterine, Ectopic, Tubal, and Others), By Complication (Miscarriage, Premature Labor & Birth, Preeclampsia, Gestational Diabetes, Placenta Previa, and Others), By Care (Prenatal Care and Postnatal Care), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 14.6%
- **2024:** $ 31.31 Billion
- **2025:** $ 35.88 Billion
- **2035:** $ 140.2 Billion
- **Key Players:** Companies such as Johnson & Johnson (US), Procter & Gamble (US), Bayer AG (DE), Merck & Co. (US), Abbott Laboratories (US), Philips Healthcare (NL), GE Healthcare (US), Hologic, Inc. (US), Ferring Pharmaceuticals (CH), MediSafe (US) are some of the major participants in the market.

**Report ID:** MRFR/Pharma/0261-HCR · **Pages:** 80 · **Author:** Nidhi Mandole & Kinjoll Dey · **Last Updated:** June 17, 2026

**URL:** https://www.marketresearchfuture.com/reports/maternal-health-market-732

---

## Market Summary

Global Maternal Health Market Size was valued at USD 31.31 Billion in 2024 & the market is projected to grow from USD 35.88 Billion in 2025 to USD 140.2 Billion by 2035, registering a CAGR of 14.60% during the forecast period 2025–2035. North America led the market with over 50.02% share, generating around USD 15.66 billion in revenue.
 
Rising awareness of maternal healthcare and increasing government initiatives to reduce maternal mortality are major growth factors driving the Maternal Health Market. Expanding access to prenatal, delivery, and postnatal services, combined with improved healthcare infrastructure, is strengthening maternal care outcomes globally.
 
Data-Centric Backup (WHO Data Portal): According to WHO, approximately 86% of pregnant women globally received at least one antenatal care visit in recent years, reflecting substantial improvements in maternal healthcare access. Increased utilization of prenatal services is supporting demand for maternal health products, monitoring solutions, and specialized care programs worldwide.

## Market Drivers

### Market Growth Projections

The Global Maternal Health Market Industry is poised for substantial growth, with projections indicating a market value of 31.3 USD Billion in 2024 and an anticipated increase to 140.2 USD Billion by 2035. This growth trajectory suggests a robust compound annual growth rate (CAGR) of 14.6% from 2025 to 2035.
 
Such figures reflect the increasing recognition of maternal health as a critical component of overall healthcare systems worldwide. The expansion of maternal health services, driven by technological advancements, government initiatives, and rising awareness, is likely to create a dynamic market landscape that addresses the diverse needs of women globally.

- World Bank data indicates that global health expenditure continues to rise across developed and emerging economies, supporting maternal healthcare infrastructure expansion. Increased healthcare investment strengthens prenatal, delivery, and postnatal care services, creating favorable conditions for sustained maternal health market growth.

###  

### Government Initiatives and Funding

Government initiatives aimed at improving maternal health are significantly influencing the Global Maternal Health Market Industry. Many countries are allocating substantial budgets to enhance maternal healthcare services, focusing on reducing maternal mortality and morbidity rates. For instance, national health programs in various regions are being funded to provide comprehensive maternal care, including prenatal check-ups and emergency obstetric services. 
 
This financial support is expected to bolster the market, with estimates suggesting a growth to 140.2 USD Billion by 2035. Such initiatives underscore the commitment of governments to prioritize maternal health, thereby driving demand for related services and products.

- According to IHME, maternal health remains a major focus area for public health investments globally. Increased allocation of healthcare resources toward maternal and neonatal care programs has contributed to continuous improvements in maternal outcomes, supporting growing demand for maternal healthcare services and technologies.

### Cultural Shifts and Empowerment of Women

Cultural shifts towards the empowerment of women are having a profound impact on the Global Maternal Health Market Industry. As women gain greater access to education and economic opportunities, they are increasingly prioritizing their health and well-being. This empowerment is leading to a demand for comprehensive maternal health services that cater to their specific needs.
 
Additionally, societal changes are fostering environments where women feel more comfortable seeking medical assistance during pregnancy and childbirth. This trend is likely to contribute to the market's growth, as empowered women advocate for better maternal health services and resources.

- Published studies in PubMed demonstrate that higher female education levels are strongly associated with increased utilization of antenatal care services and skilled birth attendance. Improved healthcare awareness among women continues to strengthen demand for comprehensive maternal healthcare solutions worldwide.

### Technological Advancements in Healthcare

Innovations in healthcare technology are playing a pivotal role in shaping the Global Maternal Health Market Industry. The integration of telemedicine, mobile health applications, and wearable devices is enhancing maternal care delivery. For example, telehealth services allow expectant mothers to consult healthcare providers remotely, improving access to care in underserved areas.
 
These advancements are not only streamlining healthcare processes but also empowering women with information and resources. As a result, the market is projected to grow at a CAGR of 14.6% from 2025 to 2035, reflecting the increasing reliance on technology to improve maternal health outcomes.

- World Bank reports increasing adoption of digital health technologies across healthcare systems globally. Expanding telehealth infrastructure is improving healthcare accessibility for pregnant women, particularly in underserved regions, supporting broader adoption of maternal health monitoring and care solutions.

### Rising Awareness of Maternal Health Issues

The Global Maternal Health Market Industry is experiencing a surge in awareness regarding maternal health issues, driven by increased advocacy and education initiatives. Governments and non-governmental organizations are actively promoting maternal prescribed health  programs, leading to improved access to prenatal and postnatal care. For instance, campaigns aimed at reducing maternal mortality rates have gained traction, particularly in developing regions.
 
This heightened awareness is expected to contribute to the market's growth, with projections indicating a market value of 31.3 USD Billion in 2024. As awareness continues to rise, the demand for maternal health services and products is likely to expand significantly.

- IHME findings show continued reductions in maternal mortality rates across numerous countries due to enhanced awareness campaigns and healthcare interventions. Increased public awareness and educational initiatives are encouraging earlier maternal care engagement and improved pregnancy management practices.

### Increasing Prevalence of High-Risk Pregnancies

The Global Maternal Health Market Industry is witnessing a rise in high-risk pregnancies, which is prompting a greater need for specialized maternal healthcare services. Factors such as advanced maternal age, pre-existing health conditions, and lifestyle choices contribute to this trend. Healthcare providers are increasingly focusing on tailored care plans to address the complexities associated with high-risk pregnancies.
 
This growing prevalence is likely to drive demand for advanced maternal health solutions, including monitoring technologies and specialized medical interventions. As the market adapts to these needs, it is anticipated to expand significantly, reflecting the evolving landscape of maternal health.

- PubMed studies indicate that pregnancies among women aged 35 years and older continue to increase globally. Advanced maternal age is associated with higher monitoring requirements, supporting demand for specialized maternal healthcare services, diagnostics, and pregnancy management solutions.

## Future Outlook

The Maternal Health Industry size is projected to reach USD 140.2 Billion by 2035, growing at a CAGR of 14.6%, driven by technological advancements, increased healthcare access, and rising awareness.

**New opportunities:**

- Telehealth platforms for prenatal consultations Wearable health monitoring devices for expectant mothers Mobile applications for maternal health education and support

By 2035, the Maternal Health Market is expected to be robust, reflecting substantial growth and innovation.

## Segment Insights

### By Application: Prenatal Care (Largest) vs. Maternal Mental Health (Fastest-Growing)

The Maternal Health Market is characterized by diverse applications including Prenatal Care, Postnatal Care, Maternal Nutrition, Family Planning, and [Maternal Mental Health](https://www.marketresearchfuture.com/reports/maternal-mental-health-market-67291). Among these, Prenatal Care holds the largest market share of 42% due to its vital role in ensuring the health of both mother and child during pregnancy. This segment is often prioritized by healthcare providers, mothers, and families, leading to a robust demand for prenatal services and products. Additionally, Maternal Nutrition and Family Planning also occupy significant portions of the market, reflecting the importance of comprehensive maternal care. On the other hand, Maternal Mental Health is emerging as the fastest-growing segment in the Maternal Health Market. Increasing awareness about the mental health challenges faced by mothers during and after pregnancy is driving growth in this area. Furthermore, there is a growing emphasis on holistic maternal care that includes addressing mental health, contributing to the rising demand for services and interventions focused on maternal mental well-being. This shift in focus represents a significant trend in the market dynamics, pointing towards a more integrated approach to maternal health.

Johnson & Johnson supports maternal healthcare initiatives through prenatal wellness and maternal care programs. Prenatal Care accounted for an estimated 42% market share in 2024, driven by increasing antenatal screening adoption, routine pregnancy monitoring, and rising awareness of maternal health management.

### By Product Type: Healthcare Services (Largest) vs. Digital Health Solutions (Fastest-Growing)

The Maternal Health Market exhibits a diverse array of product types, with Healthcare Services leading in market share with 48%, followed by Pharmaceuticals and Nutritional Supplements. These segments collectively cater to the growing demands for safe maternal care. Medical Devices and Digital Health Solutions, while smaller in share, play crucial roles in enhancing patient outcomes and access to care.

Healthcare Services: Dominant vs. Digital Health Solutions: Emerging

Healthcare Services stands as the dominant force in the Maternal Health Market, providing essential prenatal and postnatal care that directly impacts maternal and infant health outcomes. This segment benefits from a robust infrastructure and a growing emphasis on personalized care. In contrast, Digital Health Solutions is emerging rapidly, leveraging technology to improve access to maternal health information, facilitate remote monitoring, and enhance patient engagement. As maternal health increasingly incorporates technology, Digital Health Solutions is set to grow significantly, appealing to tech-savvy mothers seeking convenient and comprehensive care options.

### By End User: Hospitals (Largest) vs. Clinics (Fastest-Growing)

In the Maternal Health Market, the end-user segment exhibits a diverse array of players, with hospitals leading the market share. Hospitals are pivotal as they provide comprehensive maternal care services, encompassing labor and delivery units, prenatal services, and postpartum care. Clinics follow closely behind, serving as vital access points for prenatal checkups and maternal education. Their role in routine screenings and outpatient services solidifies their position in the overall landscape.

Hospitals (Dominant) vs. Clinics (Emerging)

Hospitals represent a dominant force in the Maternal Health Market, offering extensive resources such as specialized staff, advanced technology, and integrated services that cater to complex maternal needs. The presence of labor and delivery departments enables hospitals to handle a high volume of births and maternal care scenarios. In contrast, clinics are emerging as important players by focusing on preventive care and early intervention, addressing maternal health needs in a more personalized setting. Clinics often serve underserved populations and adapt quickly to changing patient needs, contributing significantly to maternal health delivery.

## Regional Market Share Analysis

### North America : Leading Market Innovators

North America leads in the Maternal Health Market Size, accounting for over 50.02% of the global revenue in 2024. Key growth drivers include advanced healthcare infrastructure, increasing awareness of maternal health issues, and supportive government policies. The region's regulatory environment encourages innovation, with initiatives aimed at improving maternal care and reducing maternal mortality rates.

- According to CDC data, approximately 3.6 million births occur annually in the United States, creating sustained demand for prenatal care, maternal monitoring services, postnatal support, and advanced maternal healthcare technologies throughout North America.

Demand for high-quality maternal health products continues to rise, driven by a focus on preventive care and wellness. The competitive landscape in North America is robust, featuring major players like Johnson & Johnson, Procter & Gamble, and Merck & Co. These companies are investing heavily in research and development to introduce innovative solutions tailored to maternal health needs. The U.S. leads the market, followed by Canada, with a growing emphasis on digital health solutions and telemedicine. This trend is reshaping how maternal health services are delivered, enhancing accessibility and patient engagement.

- GE HealthCare continues expanding maternal and fetal monitoring technologies used in hospitals worldwide. Advanced ultrasound and fetal monitoring systems support millions of maternal health assessments annually, helping healthcare providers improve pregnancy management, risk detection, and maternal outcomes across North America.

### Europe : Emerging Regulatory Frameworks

Europe Maternal Health Market was valued at USD 10 Billion in 2024, making it the second-largest regional market with a 31.94% share,driven by increasing investments in healthcare and a growing focus on maternal health initiatives. Regulatory frameworks across the region are evolving, with governments implementing policies to enhance maternal care and reduce health disparities. The demand for innovative maternal health products is rising, supported by public health campaigns and increased awareness of maternal health issues. Leading countries in this market include Germany, France, and the UK, where key players like Bayer AG and Philips Healthcare are actively involved.

- The European Medicines Agency continues supporting the approval and monitoring of medicines used during pregnancy and maternal care. EMA-backed regulatory frameworks help ensure patient safety and access to innovative maternal health therapies, supporting growing adoption of advanced maternal healthcare solutions across Europe.

The competitive landscape is characterized by a mix of established companies and emerging startups focusing on digital health solutions. The European market is witnessing a shift towards personalized maternal care, with an emphasis on technology integration to improve health outcomes. "The European Commission is committed to improving maternal health through comprehensive policies and initiatives that address the needs of mothers and infants," European Commission.

### Asia-Pacific : Rapidly Growing Market Potential

The Asia-Pacific region is witnessing significant growth in the Maternal Health Market, projected to reach $4.5 billion by 2025. Key drivers include rising healthcare expenditure, increasing awareness of maternal health issues, and government initiatives aimed at improving maternal care. The region's diverse population and varying healthcare access levels create unique challenges and opportunities, leading to a growing demand for tailored maternal health solutions. Countries like China and India are at the forefront of this growth, with a focus on enhancing healthcare infrastructure and maternal health services.

The competitive landscape features both multinational corporations and local players, with companies like Abbott Laboratories and Hologic, Inc. making significant contributions. The emphasis on technology and innovation is reshaping maternal health delivery, with telehealth and mobile health solutions gaining traction. The region is poised for continued growth as maternal health becomes a priority for governments and healthcare providers.

### Middle East and Africa : Emerging Health Initiatives

The Middle East and Africa (MEA) region's Maternal Health Market is valued at $1.15 billion in 2025, with growth driven by increasing healthcare investments and initiatives aimed at improving maternal health outcomes. Governments are prioritizing maternal health, implementing policies to enhance access to care and reduce maternal mortality rates. The demand for maternal health products is rising, supported by public health campaigns and international aid programs.

Leading countries in this region include South Africa and Nigeria, where local and international organizations are working to improve maternal health services. The competitive landscape is evolving, with key players like Ferring Pharmaceuticals and MediSafe focusing on innovative solutions tailored to the region's needs. The emphasis on community-based healthcare and education is crucial for addressing maternal health challenges, making it a focal point for future investments and initiatives.

## Competitive Benchmarking

The Maternal Health Market is characterized by a dynamic competitive landscape, driven by increasing awareness of maternal health issues and the growing demand for innovative healthcare solutions. Key players such as Johnson & Johnson (US), Procter & Gamble (US), and Bayer AG (DE) are strategically positioned to leverage their extensive product portfolios and research capabilities. Johnson & Johnson (US) focuses on innovation in maternal health products, while Procter & Gamble (US) emphasizes consumer engagement through educational initiatives. Bayer AG (DE) is actively pursuing partnerships to enhance its product offerings, thereby shaping a competitive environment that prioritizes innovation and collaboration.
 
In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. The market appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies like Merck & Co. (US) and Abbott Laboratories (US) is notable, as they continue to expand their reach through strategic acquisitions and partnerships, thereby consolidating their positions in the market. 
 
In November 2025, Merck & Co. (US) announced a collaboration with a leading telehealth provider to enhance access to maternal health services. This strategic move is significant as it aligns with the growing trend of digital health solutions, potentially improving maternal care accessibility and outcomes. By integrating telehealth into their offerings, Merck & Co. (US) positions itself as a forward-thinking leader in the maternal health space. 
 
In October 2025, Abbott Laboratories (US) launched a new line of prenatal vitamins specifically designed for women with dietary restrictions. This initiative reflects a keen understanding of diverse consumer needs and highlights Abbott's commitment to innovation in maternal health. By catering to a broader audience, Abbott Laboratories (US) not only enhances its product portfolio but also strengthens its market presence. 
 
In September 2025, Bayer AG (DE) expanded its partnership with a non-profit organization focused on maternal health education in underserved communities. This collaboration underscores Bayer's dedication to social responsibility and its strategic focus on community engagement. By investing in educational initiatives, Bayer AG (DE) enhances its brand reputation while addressing critical gaps in maternal health awareness. 
 
As of December 2025, the Maternal Health Market is witnessing trends such as digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise. The shift from price-based competition to a focus on innovation and technology is evident, as companies strive to differentiate themselves through reliable supply chains and cutting-edge solutions. Looking ahead, competitive differentiation will likely evolve, with an emphasis on delivering value through innovative products and services that address the unique needs of mothers and their families.

## Recent News & Developments

**June 2022:**People with obesity who underwent weight-loss surgery had a 32% lower risk of developing cancer and a 48% lower risk of dying from it, per Cleveland Clinic research. The research was published in JAMA.

## Report Scope

| MARKET SIZE 2024 | 31.31(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 35.88(USD Billion) |
| MARKET SIZE 2035 | 140.2(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 14.6% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Johnson & Johnson (US), Procter & Gamble (US), Bayer AG (DE), Merck & Co. (US), Abbott Laboratories (US), Philips Healthcare (NL), GE Healthcare (US), Hologic, Inc. (US), Ferring Pharmaceuticals (CH), MediSafe (US) |
| Segments Covered | Application, Product Type, End User |
| Key Market Opportunities | Integration of telehealth solutions enhances access to maternal care and supports remote monitoring. |
| Key Market Dynamics | Rising demand for telehealth services enhances access to maternal care amid evolving consumer preferences and regulatory frameworks. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the projected market valuation of the Maternal Health Market by 2035?**
A: The Maternal Health Market is projected to reach a valuation of 140.2 USD Billion by 2035.

**Q: What was the market valuation of the Maternal Health Market in 2024?**
A: In 2024, the overall market valuation of the Maternal Health Market was 31.31 USD Billion.

**Q: What is the expected CAGR for the Maternal Health Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the Maternal Health Market during the forecast period 2025 - 2035 is 14.6%.

**Q: Which segment of the Maternal Health Market had the highest valuation in 2024?**
A: In 2024, the Prenatal Care segment had the highest valuation at 8.0 USD Billion.

**Q: What are the key players in the Maternal Health Market?**
A: Key players in the Maternal Health Market include Johnson & Johnson, Procter & Gamble, Bayer AG, and Merck & Co.

**Q: How much is the Family Planning segment projected to be worth by 2035?**
A: The Family Planning segment is projected to reach a valuation of 30.0 USD Billion by 2035.

**Q: What is the projected valuation for the Medical Devices segment by 2035?**
A: The Medical Devices segment is projected to reach a valuation of 25.0 USD Billion by 2035.

**Q: Which end user category is expected to dominate the Maternal Health Market by 2035?**
A: By 2035, Hospitals are expected to dominate the Maternal Health Market with a projected valuation of 45.0 USD Billion.

**Q: What is the projected growth for the Maternal Nutrition segment by 2035?**
A: The Maternal Nutrition segment is projected to grow to a valuation of 22.0 USD Billion by 2035.

**Q: How does the valuation of Digital Health Solutions compare to other product types in 2024?**
A: In 2024, Digital Health Solutions had a valuation of 5.31 USD Billion, indicating a growing interest in technology-driven maternal health solutions.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/maternal-health-market-732*